MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ajrccm/aamag163

Медицинская библиотека · American journal of respiratory and critical care medicine · 2026

Cost-effectiveness of community tuberculosis screening in South Africa.

Deleger Julie N, Khatami S Nazanin, Jones Michelle, Jalali Mohammad S, Paltiel A David, Wong Emily B, Florance Grady, Freedberg Kenneth A, Wood Robin, Horsburgh C Robert, Reddy Krishna P

СтатьяПеревод в очереди

Аннотация

RATIONALE: The World Health Organization recommends community-based tuberculosis active case finding using digital chest radiography with computer-aided detection (dCXR/CAD) and/or molecular diagnostics, but clinical and economic outcomes are unclear.

OBJECTIVE

To evaluate the cost-effectiveness of community-based tuberculosis screening strategies in South Africa.

METHODS

Using a microsimulation model, we evaluated 3 symptom-agnostic screening strategies among adult people without HIV (PWoH) and people with HIV (PWH): (1) No Screening; (2) sputum Xpert Ultra (Xpert); and (3) dCXR/CAD followed by confirmatory sputum Xpert (dCXR + Xpert). Base case tuberculosis prevalence was 0.64%-1.23%. Sensitivity/specificity/cost for dCXR/CAD were 77%-90%/65%-73%/$3.55; for Xpert Ultra, they were 69%-91%/98%-99%/$15.24. Model outcomes included life-years, costs, and incremental cost-effectiveness ratios (ICERs) (<$3000/year-of-life saved [YLS] considered cost-effective). We conducted sensitivity analysis around key parameters, including test sensitivity, specificity, and cost.

MEASUREMENTS AND MAIN

RESULTS

In the base case, Xpert identifies the most individuals with tuberculosis but produces the most false positives and highest costs. Compared to Xpert, dCXR + Xpert identifies ∼13% fewer individuals with tuberculosis while decreasing screening costs by ∼45%. Given base case performance characteristics, at the lifetime horizon, dCXR + Xpert is cost-effective (ICER $610/YLS) whereas Xpert is not (ICER $3460/YLS). dCXR + Xpert remains cost-effective relative to No Screening, unless tuberculosis prevalence (PWoH/PWH) is ≤0.15%/0.45%, dCXR/CAD sensitivity is (PWoH/PWH) ≤ 20%/10%, dCXR/CAD cost is ≥$34.00, Xpert Ultra cost is ≥$135.00, or linkage to tuberculosis care is ≤15%.

CONCLUSION

Digital chest radiography with computer-aided detection followed by confirmatory sputum Xpert Ultra would likely be a cost-effective strategy for tuberculosis screening in South Africa.

Для цитирования: Deleger Julie N, Khatami S Nazanin, Jones Michelle, Jalali Mohammad S, Paltiel A David, Wong Emily B, Florance Grady, Freedberg Kenneth A, Wood Robin, Horsburgh C Robert, Reddy Krishna P. Cost-effectiveness of community tuberculosis screening in South Africa.. American journal of respiratory and critical care medicine. 2026. DOI: 10.1093/ajrccm/aamag163.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.